A practical reference on LC-MS: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-05-30 and is reviewed periodically as new material appears.
At the molecular level, SR9009 binds REV-ERBα and REV-ERBβ and alters their repressive activity on target genes. These nuclear receptors help regulate the circadian clock, lipid synthesis, glucose metabolism, and inflammatory pathways. By changing transcription, the compound can shift the timing or magnitude of downstream metabolic processes in model systems. It does not act through androgen receptors or adenosine receptors, which distinguishes it from several substances sold for athletic performance. Whether the same transcriptional changes occur in humans at tolerable exposures remains an open question because controlled human studies are lacking.
Preclinical reports describe effects on exercise endurance, mitochondrial content, and lipid profiles in rodents, but these findings come from specific experimental conditions. Many studies use high doses or delivery methods that may not translate directly to human use. SR9009 has been reported to have low oral bioavailability and a short half-life, which complicates interpretation of oral dosing studies. It is not established as safe or effective for any indication. Literature discussions often separate its pharmacological mechanism from unverified claims made in fitness and supplement markets.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not an approved medicine and has no established human therapeutic use. The compound appears in scientific literature as a tool for probing circadian and metabolic regulation. Online sellers often label it as a research chemical, sometimes using the nickname Stenabolic. Its chemical identity is distinct from selective androgen receptor modulators, stimulants, and peroxisome proliferator-activated receptor delta agonists. Researchers use it mainly in cell and animal experiments.
SR9009 is a synthetic small molecule that acts on the nuclear receptors REV-ERBα and REV-ERBβ. These receptors are part of the circadian clock machinery and normally repress transcription of certain target genes. In laboratory research, SR9009 is used as a chemical tool to study how REV-ERB activity influences metabolism, inflammation, and daily biological rhythms. The compound is not an approved medicine, and its effects in humans remain largely uncharacterized. It is often described as an investigational agent rather than a therapeutic product.
REV-ERB proteins typically suppress gene expression by recruiting corepressor complexes to DNA response elements. SR9009 binds these receptors and strengthens that repressive action in cell-based assays. Studies in rodents have reported changes in lipid handling, mitochondrial function, and exercise capacity after treatment. Such findings are often cited as evidence for metabolic effects, but species differences and limited pharmacokinetic data make direct translation to humans uncertain. Researchers continue to examine which effects are robust and which depend on specific experimental conditions.
SR9009 is frequently discussed alongside other REV-ERB ligands, including synthetic agonists and natural heme-related molecules. Its selectivity for REV-ERB over related nuclear receptors has been measured in binding and reporter assays, though off-target activity at higher concentrations is possible. The compound is prohibited in sport by the World Anti-Doping Agency, and it is not approved for any medical use in major jurisdictions. Products sold online may be labeled as research chemicals, and their identity and purity are not guaranteed by regulatory review.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C20H24ClN3O4S | Derived from published structure. |
| Molecular weight | 437.94 g/mol | Calculated value. |
| Appearance | White to off-white solid | Typical for purified research samples. |
| Solubility | DMSO, ethanol; low in water | Class: poorly water-soluble. |
| Typical storage | -20 °C, desiccated, protected from light | Limits degradation. |
Physicochemical behavior influences handling. SR9009 is described as a solid with limited aqueous solubility, so organic solvents such as dimethyl sulfoxide or ethanol are common in research stock solutions. Aqueous dilution can produce precipitates if the organic content is too low. Light, heat, and repeated freeze-thaw cycles may affect stability. Storage recommendations usually specify a desiccated freezer environment protected from light, but exact stability data depend on the formulation and matrix.
Detection in biological samples can be complicated by rapid metabolism and low circulating concentrations. Some studies report phase I and phase II metabolites, and analytical methods may need to target those species in addition to the parent compound. Immunoassays are not broadly available, so mass spectrometry remains the main confirmatory approach. For anti-doping testing, laboratories look for SR9009 and its metabolites using validated LC-MS methods. Open questions include how long metabolites remain detectable and how different routes of administration alter detection windows.
In laboratory settings, SR9009 is typically characterized by liquid chromatography–mass spectrometry (LC-MS) or high-performance liquid chromatography with ultraviolet detection (HPLC-UV). These methods can confirm identity and estimate purity, but they require reference standards for accurate quantification. Because SR9009 is not a licensed pharmaceutical, no harmonized pharmacopeial monograph exists. Laboratories often validate in-house methods for matrices such as plasma, urine, or cell culture media. Sample preparation may involve protein precipitation or liquid-liquid extraction before analysis.
Agriculture is the most important economic sector of Somalia. It accounts for about 65% of the GDP and employs 65% of the workforce. Livestock contributes about 40% to GDP and more than 50% of export earnings. Other principal exports include fish, charcoal and bananas; sugar, sorghum and corn are products for the domestic market. According to the Central Bank of Somalia, imports of goods total about US$460 million per year, surpassing aggregate imports prior to the start of the civil war in 1991. Exports, which total about US$270 million annually, have also surpassed pre-war aggregate export levels. Somalia has a trade deficit of about US$190 million per year, but this is exceeded by remittances sent by Somalis in the diaspora, estimated to be about US$1 billion.
American Brugmansia and Datura Society, Inc. (ABADS) is designated in the 2004 edition of the International Code of Nomenclature for Cultivated Plants as the official International Cultivar Registration Authority for Datura. This role was delegated to ABADS by the International Society for Horticultural Science in 2002.
== Pathophysiology == Myopathies share a final common feature of impaired skeletal muscle fibre function, but arise through diverse mechanisms that underpin their classification. In the inherited myopathies, pathogenic variants disrupt structural proteins of the muscle membrane and cytoskeleton (as in the muscular dystrophies), ion channels (the channelopathies and myotonias), or the enzymes of muscle energy metabolism. Contemporary classification frameworks increasingly integrate the underlying genotype and pathomechanism alongside the clinical phenotype. In metabolic myopathies, defects affecting glycogen, lipid or mitochondrial metabolism impair the production of adenosine triphosphate (ATP) within the muscle cell, so that symptoms are often dynamic and precipitated by exertion rather than static. In the idiopathic inflammatory myopathies, immune-mediated injury produces endomysial inflammation, and the predominant immunopathology differs between subtypes, supporting a clinico-sero-pathological classification into dermatomyositis, polymyositis, immune-mediated necrotising myopathy, anti-synthetase/overlap myositis and inclusion-body myositis. Acquired myopathies of systemic disease similarly act through distinct routes, including endocrine dysregulation, drug and toxin exposure, critical illness and paraneoplastic mechanisms.
Sources: en.wikipedia.org
Put simply, the biggest limits of applying such transplantation more widely were not cost or surgical skill (as formidable as those are) but rather the problem of allograft rejection and the scarcity of donor organs. Ciclosporin was a major advancement against the rejection part of the challenge.
Dermatitis repens (acrodermatitis continua, acrodermatitis continua of Hallopeau, acrodermatitis continua suppurativa Hallopeau, acrodermatitis perstans, dermatitis repens Crocker, Hallopeau's acrodermatitis, Hallopeau's acrodermatitis continua, pustular acrodermatitis) Infantile acropustulosis (acropustulosis of infancy) Palmoplantar pustulosis (persistent palmoplantar pustulosis, pustular psoriasis of the Barber type, pustular psoriasis of the extremities, pustulosis of palms and soles, pustulosis palmaris et plantaris) Pustular bacterid
==== Short-term ==== Acute adverse effects are usually the result of high or multiple doses, although single dose toxicity can occur in susceptible individuals. The most serious short-term physical health risks of MDMA are hyperthermia and dehydration. Cases of life-threatening or fatal hyponatremia (excessively low sodium concentration in the blood) have developed in MDMA users attempting to prevent dehydration by consuming excessive amounts of water without replenishing electrolytes. The immediate adverse effects of MDMA use can include:
=== High-throughput === Due to the highly time-consuming and work-intensive standard procedure, the method of in-gel digestion was limited to a relatively small number of protein spots to be processed at a time. Therefore, it has been found to be the ideal object for automation ambitions to overcome these limitations for industrial and service laboratories. Today, in laboratories where in-gel digestion is performed in high-throughput quantities, the procedure is usually automated. The degree of automation varies from simple pipetting robots to highly sophisticated all-in-one solutions, offering an automated workflow from gel to mass spectrometry. The systems usually consist of a spot picker, a digestion robot, and a spotter. The advantages of the automation other than the larger number of spots to be processed at a time are the reduced manual work and the improved standardisation. Due to the many handling steps of the method, the results of the manual process could vary depending on the dexterity of the user and the risk of contamination is high. Therefore, the quality of the results is described to be one main advantage of the automated process. Drawbacks of automated solutions are the costs for robots, maintenance and consumables as well as the complicated setup of the process. Since the automated picking needs digitised information of the spot location, the analysis of the gel image for relevant spots has to be done by software requiring standardised imaging methods and special scanners.
Sources: en.wikipedia.org
According to scholar Ray Jabre Mouawad, the Druze appreciated the two saints for their bravery, Saint George because he confronted the dragon and the Prophet Elijah because he competed with the pagan priests of Baal and won over them. In both cases the explanations provided by Christians are that Druzes were attracted to warrior saints that resemble their own militarized society. Saint George is considered the patron saint of Lebanese Christians, Palestinian Christians, Syrian Christians, and the Druze. Salman the Persian is honored as a prophet in the Druze faith, and as an incarnation of the monotheistic idea. As a practicing Zoroastrian, he dedicated much of his early life to studying to become a magus, though he later became preoccupied with travelling throughout Western Asia to engage in interfaith dialogue with other religious groups. His quests eventually prompted his conversion to Christianity and later his conversion to Islam, which occurred after he met and befriended Muhammad in the city of Yathrib. In 587 he met a Nestorian Christian group and was impressed by them. Against the wishes of his father, he left his family to join them. His family imprisoned him afterwards to prevent him but he escaped.
== Career == Using the profits from his construction business on Long Island, Kimmel and his friend, Milton Cooper, moved to Florida and founded the Kimco Realty Corporation in 1958. Kimco derives its name from the surnames of the two founders. They correctly presaged that Florida was in the midst of transitioning from a vacation destination to a retirement haven. Their first investment was a small strip mall with two stores attached to a Zayre's. Sticking to the same formula - focusing on strip developments in new subdivisions (often following utility trucks out to find new developments - they were wildly successful and over the next thirty years, Kimco's portfolio grew to over 1,900 properties of which 1,100 were strip shopping centers. Their business expanded internationally and included properties in Canada, Mexico, Chile and Brazil. The company went public in 1991 raising $128 million becoming the first Real Estate Investment Trust (REIT) IPO in history. Kimmel retired in 1991 to focus on philanthropic activities.
Austin participated in the Royal Rumble match, where he was the last wrestler eliminated by the winner Mr. McMahon. Austin defeated McMahon St. Valentine's Day Massacre in a steel cage match, winning the championship opportunity at WrestleMania XV, where he defeated The Rock to win his third WWF Championship. Austin faced The Rock in a rematch the following month at Backlash. Austin would lose the championship to The Undertaker at Over the Edge. Due to events revolving around Vince, Stephanie and Linda McMahon made Austin the chief executive officer (CEO) of the company as part of the storyline. Vince and Shane challenged Austin to a handicap ladder match at King of the Ring with the title of CEO on the line, which the McMahons won. The next night on Raw, Austin challenged and defeated The Undertaker to win his fourth WWF Championship. The two would compete in a "First Blood" match at Fully Loaded, with the stipulation that if Austin lost he would never compete for the WWF Championship again, but if Austin won, Vince would depart the company; Austin won after interference from X-Pac.
=== Food processing levels === The level of measurement in food processing classification uses nominal or ordinal variables for qualitative grouping of food processing. Processed food classifications, such as the Nova classification, categorise processed foods and often use subjective criteria in processed foods grouping. Nominal food processing classifications group food processing according to qualitative variables, such as raw material sources, purpose of processing, traditional or novel, and type of treatment. Food processing levels (FPL) are derived from ordinal scaling of food processing impact on processed foods. Food processing levels (Table 1) indicate the object and result of food processing and provide means for the use of the extent of food processing at an ordinal scale for various purposes, e.g., processed food classification. The relative impact of FPL on the expected extent of food processing results from the combined effects of physical and chemical changes during food processing as is described in Figure 1.
===== MeSH D08.811.682.608 – nadh, nadph oxidoreductases ===== MeSH D08.811.682.608.047 – apoptosis inducing factor MeSH D08.811.682.608.191 – cytochrome reductases MeSH D08.811.682.608.191.237 – cytochrome-b(5) reductase MeSH D08.811.682.608.191.500 – nadph-ferrihemoprotein reductase MeSH D08.811.682.608.504 – electron transport complex i MeSH D08.811.682.608.504.500 – nadh dehydrogenase MeSH D08.811.682.608.530 – nadh tetrazolium reductase MeSH D08.811.682.608.540 – nadp transhydrogenase MeSH D08.811.682.608.550 – nadph dehydrogenase MeSH D08.811.682.608.575 – nadph oxidase MeSH D08.811.682.608.800 – quinone reductases MeSH D08.811.682.608.800.500 – nad(p)h dehydrogenase (quinone) MeSH D08.811.682.608.800.500.500 – zeta-crystallins
Sources: en.wikipedia.org
SR9009 is a synthetic REV-ERB agonist used in laboratory research. It is not an approved drug, and its effects in humans are not well characterized. It is often sold as a research chemical under the name Stenabolic.
No. SR9009 targets the nuclear receptors REV-ERBα and REV-ERBβ, not the androgen receptor. This mechanism differs from selective androgen receptor modulators and from exercise mimetics that act on PPARδ.
Published evidence is mainly preclinical, using cell cultures and animal models. Controlled human trials are not well documented in the public literature. Claims about human performance or health effects therefore remain unsupported by robust clinical data.
SR9009 is a synthetic research compound that binds and modulates the nuclear receptors REV-ERBα and REV-ERBβ. It is used in laboratory studies of circadian biology and metabolism, not as an approved medicine. It is also known by the informal name Stenabolic.